Assistant Professor - medical
Strategic program(s):
Research aim
Our research aims to revolutionise cancer treatment by advancing innovative immunotherapies, ensuring safer, more effective therapies, and improving patient outcomes, ultimately transforming lives through cutting-edge translational cancer research.
Go to groupbestuurslid - werkgroep - HOVON
Lid - Werkgroep - HOVON MPN werkgroep
Lid - Member Registry Committee - EBMT
Member - Data Safety Monitoring Board Miltenyi DALY trials - Miltenyi
Lid - organisatie DHC congres - NVVH